The Licorice Flavonoid Isoliquiritigenin Suppresses Phorbol Ester-induced Cyclooxygenase-2 Expression in the Non-tumorigenic MCF-10A Breast Cell Line

Abstract

Cyclooxygenase (COX) is the rate-limiting enzyme for the conversion of prostaglandins from arachidonic acid. Upregulation of COX-2 has been well documented during tumorigenesis and metastasis of breast cancer. Isoliquiritigenin (ILN), a flavonoid isolated from licorice (the rhizomes of Glycyrrhiza glabra, a member of the bean plant family), is known to be a potential suppressor of COX-2 expression. This study focuses on phorbol ester-induced COX-2 expression in the non-tumorigenic MCF-10A cells. Real-time PCR and Western blotting indicated that ILN at 5 µM or above significantly inhibited phorbol 12-myristate 13-acetate (PMA)-induced COX-2 expression in the breast cells. The activated PKCα appeared to be not affected, whereas its downstream mitogen-activated protein kinase (MAPK) ERK-1/2 was deactivated. ERK can activate the transcriptional factor binding of AP-1 or CRE, which can be located at the COX-2 promoter region (− 72/− 53). Electrophoretic mobility shift assays illustrated that ILN suppressed DNA binding at this region. The shifted bands could be competed off with consensus sequences of AP-1 and CRE, and the supershift assay demonstrated that CREB-1 instead of c-Jun was responsible for the binding. This study showed that ILN downregulated PMA-induced COX-2 expression by modulating ERK-1/2 signaling, a finding that may be relevant to the disease prevention properties of licorice.

Key words

isoliquiritigenin - Glycyrrhiza glabra - Fabaceae - COX‐2 - breast cell line

References

• 1 Singh B, Lucci A. Role of cyclooxygenase-2 in breast cancer.  J Surg Res. 2002;  108 173-179
• 2 Gupta R A, DuBois R N. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.  Nat Rev Cancer. 2001;  1 11-21
• 3 Soslow R, Dannenberg A, Rush D, Woerner B M, Khan K N, Masferrer J, Koki A T. COX-2 is expressed in human pulmonary, colonic, and mammary tumors.  Cancer. 2000;  89 2637-2645
• 4 Kis B, Snipes J A, Busija D W. Acetaminophen and the cyclooxygenase-3 puzzle: sorting out facts, fictions, and uncertainties.  J Pharmacol Exp Ther. 2005;  315 1-7
• 5 Howe L R, Subbaramaiah K, Brown A M C, Dannenberg A J. Cyclooxygenase-2: a target for the prevention and treatment of breast cancer.  Endocr Relat Cancer. 2001;  8 97-114
• 6 Prosperi J R, Mallery S R, Kigerl K A, Erfurt A A, Robertson F M. Invasive and angiogenic phenotype of MCF-7 human breast tumor cells expressing human cyclooxygenase-2.  Prostaglandins Other Lipid Mediat. 2004;  73 249-264
• 7 Takahashi Y, Kawahara F, Noguchi M, Miwa K, Sato H, Seiki M, Inoue H, Tanabe T, Yoshimoto T. Activation of matrix metalloproteinase-2 in human breast cancer cells over-expressing cyclooxygenase-1 or -2.  FEBS Lett. 1999;  460 145-148
• 8 Trifan O C, Hla T. Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis.  J Cell Mol Med. 2003;  7 207-222
• 9 Dong Z, Birrer M J, Watts R G, Matrisian L M, Colburn N H. Blocking of tumor promoterinduced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells.  Proc Natl Acad Sci USA. 1994;  91 609-613
• 10 Subbaramaiah K, Norton L, Gerald W, Dannenberg A J. Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer – evidence for involvement of AP-1 and PEA3.  J Biol Chem. 2002;  277 18649-18657
• 11 Subbaramaiah K, Chung W J, Michaluart P, Telang N, Tanabe T, Inoue H, Jang M, Pezzuto J M, Dannenberg A J. Resveratrol inhibits cyclooxygeanse-2 transcription and activity in phorbol ester-treated human mammary epithelial cells.  J Biol Chem. 1998;  273 21875-21882
• 12 Miller C, Zhang M, He Y, Zhao J, Pelletier J-P, Martel-Pelletier J, Di Battista J A. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins.  J Cell Biochem. 1998;  69 392-413
• 13 Sun Y, Wenger L, Brinckerhoff C E, Misra R R, Cheung H S. Basic calcium phosphate crystals induce matrix metalloproteinase-1 through the Ras/mitogen-activated protein kinase/c-fos/AP-1/metalloproteinase 1 pathway.  J Biol Chem. 2002;  277 1544-1552
• 14 Harris R E, Alshafie G A, Abou-Issa H, Seibert K. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor.  Cancer Res. 2000;  60 2101-2103
• 15 Nakatsugi S, Hhta T, Kawamori T, Mutoh M, Tanigawa T, Watanabe K, Sugie S, Sugimura T, Wakabayashi K. Chemoprevention by nimesulide, a selective cyclooxygenase-2 inhibitor of 2-amino-1-methyl-6-phenylimidazol [4, 5-b]pyridine (PhIP)-induced mammary gland carcinogenesis in rats.  Jpn J Cancer Res. 2000;  91 886-892
• 16 Howe L R, Subbaramaiah K, Patel J, Masferrer J L, Deora A, Hudis C, Thaler H T, Muller W J, Du B, Brown A M, Dannenberg A J. Celecoxib, a selective cyclooxygenase-2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neuinduced breast cancer.  Cancer Res. 2002;  62 5405-5407
• 17 Arun B, Zhang H, Mirza N Q, Hortobagyi G N, Hung M C, Meric F. Growth inhibition of breast cancer cells by celecoxib.  Breast Cancer Res Treat. 2001;  69 234
• 18 Yu S M, Kuo S C. Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta.  Br J Pharmacol. 1995;  114 1587-1594
• 19 Tawata M, Aida K, Noguchi T, Ozaki Y, Kume S, Sasaki H, Chin M, Onaya T. Antiplatelet action of isoliquiritigenin, an aldose reductase inhibitor in licorice.  Eur J Pharmacol. 1992;  212 87-92
• 20 Takahashi T, Takasuka N, Iigo M, Baba M, Nishino H, Tsuda H, Okuyama T. Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development.  Cancer Sci. 2004;  95 448-453
• 21 Yamamoto S, Aizu E, Jiang H, Nakadate T, Kiyoto I, Wang J C, Kato R. The potent anti-tumor-promoting agent isoliquiritigenin.  Carcinogenesis. 1991;  12 317-323
• 22 Baba M, Asano R, Takigami I, Takahashi T, Ohmura M, Okada Y, Sugimoto H, Arika T, Nishino H, Okuyama T. Studies on cancer chemoprevention by traditional folk medicines XXV. Inhibitory effect of isoliquiritigenin on azoxymethane-induced murine colon aberrant crypt focus formation and carcinogenesis.  Biol Pharm Bull. 2002;  25 247-250
• 23 Livak K J, Schmittgen T D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method.  Methods. 2001;  25 402-408
• 24 Subbaramaiah K, Michaluart P, Sporn M B, Dannenberg A J. Ursolic acid inhibits cyclooxygenase-2 transcrition in human mammary epithelial cells.  Cancer Res. 2000;  60 2399-2404
• 25 Kosaka T, Miyata A, Ihara H, Hara S, Sugimoto T, Takeda O, Takahashi E, Tanabe T. Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2.  Eur J Biochem. 1994;  221 889-897
• 26 Mutoh M, Takahashi M, Fukuda K, Matsushima-Hibiya Y, Mutoh H, Sugimura T, Wakabayashi K. Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure.  Carcinogenesis. 2000;  21 959-963
• 27 Richard N, Porath D, Radspieler A, Schwager J. Effects of resveratrol, piceatannol, triacetoxystilbene, and genistein on the inflammatory response of human peripheral blood leukocytes.  Mol Nutr Food Res. 2005;  49 431-442
• 28 Altundag K, Altunday O, Gunduz M, Arun B. Possible interaction between activator protein-1nd proto-oncogene B-cell lymphoma gene 6 in breast cancer patients resistant to tamoxifen.  Med Hypotheses. 2004;  63 823-826
• 29 Zhang F, Altorki N K, Mestre J R, Subbaramaiah K, Dannenberg A J. Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells.  Carcinogenesis. 1999;  20 445-451
• 30 Subbaramaiah K, Cole P A, Dannenberg A J. Retinoids and carnosol suppress cyclooxygenase-2 transcription by CREB-binding protein/p 300-dependent and independent mechanisms.  Cancer Res. 2002;  62 2522-2530
• 31 Kundu J K, Na H K, Chun K S, Kim Y K, Lee S J, Lee S S, Lee O S, Sim Y C, Surh Y J. Inhibition of phorbol ester-induced COX-2 expression by epigallocatechin gallate in mouse skin and cultured human mammary epithelial cells.  J Nutr. 2003;  133 3805S-3810S
• 32 Li L, Liang S, Du F, Li C. Simultaneous quantification of multiple licorice flavonoids in rat plasma.  J Am Soc Mass Spectrom. 2007;  18 778-782